The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: A prospective study

Archives of Gynecology and Obstetrics

Volumn 275, Issue 5, 2007, Pages 373-379

  Lijoi, Davide ^a   Capua, Elisa Di ^a   Ferrero, Simone ^a   Mistrangelo, Emanuela ^a   Giannattasio, Alessandro ^b   Morano, Sandra ^a   Ragni, Nicola ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

2002 CDC guidelines; GBS culture based screening; GBS vertical transmission; Group B Streptococcus (GBS); Intrapartum chemoprophylaxis

Indexed keywords

AMPICILLIN; CEFAZOLIN; CLINDAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRACTICE GUIDELINE; PREGNANT WOMAN; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CARRIER STATE; CEFAZOLIN; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHEMOPREVENTION; CLINDAMYCIN; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; ITALY; NEONATAL SCREENING; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RECTUM; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES; VAGINA; VANCOMYCIN;

EID: 33947528520     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0263-7     Document Type: Article

References (30)

1. Eickoff TC, Klein JO, Daly AK, Ingall D, Finland M (1964) Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N Engl J Med 271:1221-1228
2. Schrag SJ, Zell ER, Lynfield R et al (2002) A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347:233-239
3. Davies H, LeBlanc J, Bortolussi R, McGeer A (1999) The pediatric investigators collaborative network on infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. Pediatr Child Health 4:257-263
4. Davies HD, Raj S, Adair C, Robinson J, McGeer A (2001) Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 20:879-884
5. Schuchat A (1998) Epidemiology of group B streptococcal disease in tha United States: shifting paradigm. Clin Microbiol Rev 11:497-513
6. Schuchat A (1999) Group B streptococcus. Lancet 353:51-56
7. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15-20
8. American Academy of Pediatrics (1997) Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99:489-496
9. Hall RT, Barnes W, Krishan L, Harris DJ, Rhodes PG, Fayez J, et al (1976) Antibiotic treatment of parturient women colonized with group B streptococci. Am J Obstet Gynecol 124:630-634
10. Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ (1979) Failure of penicillin to eradicate group B streptococcal colonization in the pregnant women: a couple study. Am J Obstet Gynecol 135:1062-1065
11. Committee on Obstetric Practice (1996) American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns: ACOG Committee Opinion No. 173. Washington, ACOG
12. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A (2002) A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347:233-239
13. Prevention of perinatal group B streptococcal disease (2002) Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1-22
14. Prevention of early-onset group B streptococcal disease in newborns (2002) ACOG Committee Opinion No. 279. American College of Obstetricians and Gynecologists. Obstet Gynecol 100:1405-1412
15. Gilbert GL, Hewitt MC, Turner CM, Leeder SR (2002) Epidemiology and predictive values of risk factor for neonatal group B streptococcal sepsis. Aust NZ J Obstet Gynaecol 42:497-503
16. Sweet RL, Gibbs RS (2002) Group B Streptococci. In: Sweet RL, Gibb RS (eds) Infectious diseases of the female genital tract, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 31-46
17. Nemunaitis-Keller J, Gill P (2003) Limititations of the obstetric group B Streptococcus protocol. J Reprod Med 48(2):107-111
18. Chandran L, Navaie-Waliser M, Zulqarni NJ, Batra S, Bayir H, Shah M, Lincoln PP (2001) Compliance with group B streptococcal disease prevention guidelines. MCN Am J Matern Child Nurs 26(6):313-319
19. Simoes JA, Aroutcheva AA, Heimler I, Faro S (2004) Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol 12:1-8
20. Rouse DJ, Andrews WW, Lin FC et al (1998) Antibiotic susceptibility profile of GBS acquired vertically. Obstet Gynecol 92:931-934
21. Betriu C, Gomez M, Sanchez A et al (1994) Antibiotic resistance and penicillin tolerance in clinical isolates of GBS. Antimicrob Agents Chemother 38:2183-2186
22. Liu JW, Wu JJ, Ko WC, Chuang YC (1997) Clinical characteristics and antimicrobial susceptibility of invasive GBS infection in non pregnant adults in Taiwan. J Formos Med Assoc 96:628-633
23. Levine EM, Ghai V, Barton JJ, Strom CM (1999) Intrapartum antibiotic prophylaxis increases the incidence of Gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 7:210-213
24. Mercier BM, Carr TL, Beazley DD, Crouse DT, Sibai BM (1999) Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 181:816-821
25. The International Collaborative Study of Severe Anaphylaxis (2003) Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 12:195-202
26. Neugut AI, Ghatak AT, Miller RL (2001) Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 161:15-21
27. Dunn AB, Blomquist J, Khouzami V (1999) Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. J Reprod Med 44:381-384
28. Miller EL (2002) The penicillins: a review and update. J Midwifery Womens Health 47:426-434
29. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA (2004) Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 39:1129-1135
30. Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R (2005) The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 23:3187-3195